Anavex Life Sciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Dec '25 Dec 3, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	2016 - 2020
Market Capitalization	338	652	432	507	820	1,173	Upgrade
Market Cap Growth	-43.46%	50.88%	-14.85%	-38.17%	-30.06%	402.86%	Upgrade
Enterprise Value	250	565	307	361	664	1,037	Upgrade
Last Close Price	3.70	7.25	4.96	6.35	9.69	15.20	Upgrade
PB Ratio	4.18	8.06	4.01	3.78	5.65	9.01	Upgrade
P/TBV Ratio	4.18	8.06	4.01	3.78	5.65	9.01	Upgrade
Quick Ratio	11.56	11.56	8.80	12.27	14.92	14.93	Upgrade
Current Ratio	11.61	11.61	8.86	12.32	14.95	14.97	Upgrade
Return on Equity (ROE)	-43.11%	-43.11%	-32.81%	-33.41%	-32.71%	-42.58%	Upgrade
Return on Assets (ROA)	-26.51%	-26.51%	-21.81%	-21.59%	-18.95%	-23.87%	Upgrade
Return on Capital (ROIC)	-29.49%	-29.49%	-24.12%	-23.32%	-20.31%	-26.29%	Upgrade
Return on Capital Employed (ROCE)	-53.50%	-53.50%	-42.10%	-37.40%	-33.40%	-24.80%	Upgrade
Earnings Yield	-11.70%	-6.07%	-8.93%	-8.85%	-5.96%	-2.79%	Upgrade
Buyback Yield / Dilution	-2.18%	-2.18%	-4.61%	-3.74%	-10.18%	-19.95%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.